CurrentKaiser PermanentePolicy N/A

Clinical Review Criteria: Cardiac Ambulatory Monitoring for Extended Duration

Clinical review criteria governing medical necessity and coverage for extended ambulatory cardiac monitoring devices (implantable loop recorders, external loop recorders, MCOT/CardioNet, Zio®Patch, Holter) for Kaiser Foundation Health Plan of Washington members and providers.

Policy Summary

PayerKaiser Permanente

PolicyCardiac Ambulatory Monitoring for Extended Duration (Clinical Review Criteria)

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionFor implantable loop recorder, ensure noninvasive monitoring is unrevealing or contraindicated after a minimum 14-day period before ILR is indicated.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

30 daysMCOT / external telemetry max

14 monthsILR monitoring duration

59%ILR diagnostic yield (one study)

5-28%24–48 hr Holter yield

Coverage Criteria for Ambulatory Cardiac Monitoring

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Implantable Loop Recorder—Medically Necessary Criteria

Implantable loop recorder may be indicated when ONE or more of the following groups of conditions are met:

Atrial fibrillation (known or suspected): ALL of the following: Cryptogenic stroke confirmed by neurology; Noninvasive cardiac monitor contraindicated, or results unrevealing or inconclusive after minimum 14-day period; Recurrent paroxysmal atrial fibrillation suspected, and test results may impact patient management

From policy ILR indication A.

Syncope: ALL of the following: i. Cardiac etiology of syncope suspected as indicated by one or more of the following: abnormal ECG (eg, rhythm other than normal sinus, significant conduction abnormalities, Brugada pattern, long QT), family history of sudden death, chronic heart failure, structural heart disease (eg, severe coronary disease, hypertrophic cardiomyopathy, valvular aortic stenosis, congenital heart disease), recent palpitations/ symptomatic arrhythmia, or use of medications known to cause malignant arrhythmias (eg, antiarrhythmics, antidepressants, antihistamines); ii. Recurrent syncope suspected; iii. Test results negative or inconclusive as indicated by one or more of the following: electrophysiologic study, non-implantable (external) loop recorder worn for at least 14 days, or tilt table testing

From policy ILR indication B.

External monitoring and MCOT

Coverage statements for external monitors differ by device and member type:

External mobile cardiovascular telemetry / MCOT: Used for continuous real-time monitoring with attended surveillance for up to 30 days; considered medically necessary for Medicare when criteria in applicable policy statements are met; for non-Medicare members, medical necessity review is no longer required for listed CPT codes (eg, 93228, 93229, 93270, 93271)up to 30 days

Includes CardioNet/MCOT device descriptions and durations.

Zio®Patch and similar leadless monitors: Used for extended noninvasive monitoring but MTAC concluded evidence is insufficient to meet Medical Technology Assessment criteria and did not establish superiority or improved health outcomes compared with other long-term monitors

Evidence conclusion from MTAC review.

External patient-activated EKG: Medicare: considered not medically necessary; Non-Medicare: medical necessity review no longer required (may be administratively handled differently)

Medicare distinction noted in policy.

For Medicare members, external patient-activated electrocardiographic monitoring is considered not medically necessary and may be denied when billed under Medicare. Non‑Medicare plans no longer require medical necessity review for this category; verify authorization requirements by plan when submitting claims.

Kaiser Permanente Medical Technology Assessment Committee (MTAC) reviews found that evidence for several extended ambulatory monitors did not meet MTAC criteria. For MCOT/CardioNet, MTAC concluded there is only fair evidence from one randomized controlled trial with limitations suggesting higher diagnostic yield versus patient-activated external loop monitoring for up to one month, but insufficient evidence that MCOT is superior to auto-triggered loop or implanted loop systems or that it improves patient health outcomes. For the Zio®Patch, MTAC judged available evidence to be weak (small, single-center studies) and insufficient to demonstrate equivalence or superiority to other long-term monitors. For the implantable loop recorder (ILR), early studies reported a diagnostic yield (one study 59% over ~10.5 months) but were limited by potential selection bias, conflicts of interest, and lack of direct comparison to external loop recorders; MTAC concluded evidence did not meet medical technology assessment criteria. Overall limitations cited include small sample sizes, single-center designs, lack of comparative data versus established monitors, and insufficient evidence of impact on clinical outcomes.

Coding and Definitions

Implantable Loop Recorder CPTCPTCovered

33285

Insertion, subcutaneous cardiac rhythm monitor, including programming.

Implantable Loop Recorder HCPCSHCPCSCovered

C1764	Event recorder, cardiac (implantable).
E0616	Implantable cardiac event recorder with memory, activator, and programmer.

External telemetry / loop recorder CPTCPTCovered

93228	External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; review and interpretation with report by a physician or other qualified health care professional.
93229	External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional.
93270	External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; recording (includes connection, recording, and disconnection).
93271	External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; transmission and analysis.

External patient-activated EKGneutralNot Covered

No codes listed

inv-09: Minimum prior noninvasive monitoring period before ILR for cryptogenic stroke

Minimum prior noninvasive monitoring period>= 14 days

Prior Authorization, Documentation, and Billing Guidance

Prior Authorization

Authorization and applicable codes

Prior authorization/medical necessity review is not required for non‑Medicare members for listed external monitoring CPT codes; implantable loop recorder is considered medically necessary when criteria are met and the specified CPT/HCPCS codes apply.

Non‑Medicare: medical necessity review no longer required for CPT 93228, 93229, 93270, 93271 (external telemetry/MCOT/extended external event monitors).
Implantable loop recorder: considered medically necessary when policy criteria are met; applicable codes include CPT 33285 and HCPCS C1764, E0616.

Step Therapy

Require ≥14 days noninvasive monitoring before ILR

Before placement of an implantable loop recorder for cryptogenic stroke or similar indications, noninvasive cardiac monitoring must be contraindicated or have been unrevealing/inconclusive after at least a 14‑day monitoring period.

Policy specifies noninvasive (external) loop recorder worn for 14 days at a minimum as part of the ILR indication criteria.

Documentation Required

Required documentation to support requests

Include contemporaneous clinical and imaging documentation to support medical necessity when requesting monitoring services.

Submit the last 6 months of clinical notes from the requesting provider and/or specialist.
Submit the last 6 months of radiology notes, if applicable.

Denial Risk

Medicare denial risk for external patient‑activated EKG

External patient‑activated EKG is considered not medically necessary for Medicare members and may be denied when billed under Medicare.

For Medicare members, external patient‑activated EKG is listed as not medically necessary.
Non‑Medicare plans: medical necessity review for external patient‑activated EKG is no longer required (per policy distinctions).

Clinical Background and Rationale

Extended ambulatory ECG monitoring is used to detect infrequent or asymptomatic arrhythmias that routine in‑office ECGs and short Holter recordings may miss. Holter monitors record continuously for up to 48 hours and are useful for capturing daily events but have a limited diagnostic yield for less frequent symptoms. To extend detection windows, external loop recorders and MCOT provide monitoring up to 30 days (MCOT includes real‑time transmission and attended surveillance), while implantable loop recorders (ILR) are subcutaneously implanted devices that can store ECG data and monitor patients for up to approximately 14 months. The choice among devices balances monitoring duration, continuous versus patient‑activated recording, and the clinical question (e.g., suspected paroxysmal atrial fibrillation or unexplained syncope).

Device Definitions and Typical Monitoring Durations

inv-15: Holter monitor

DefinitionPortable device that records heart rhythms continuously for up to 48 hours to capture events that occur at least once a day (2–3 channel ECG).

Typical recording windowUp to 24–48 hours; most commonly used method for extended ECG recording.

Primary useCapture daily symptomatic events and provide complete rhythm recording with high-quality tracings.

inv-16: External loop recorder

DefinitionPortable intermittent recorder worn up to 30 days that records ECG data before, during, and after activation; may be patient-activated or automatically triggered.

Typical recording windowUp to 30 days.

Activation modesPatient-activated (requires user initiation) or automatic/auto-triggered based on algorithm-detected arrhythmias.

inv-17: MCOT / External mobile cardiovascular telemetry

DefinitionContinuous real-time ambulatory monitoring with automatic transmission to a remote surveillance center and attended review by technicians and clinicians.

Typical recording windowUp to 30 days with 24-hour/day monitoring.

Key featuresAutomated arrhythmia detection, wireless transmission of triggered or patient-selected events, attended surveillance and physician notification.

inv-18: Implantable loop recorder (ILR)

DefinitionSubcutaneously implanted cardiac recorder that stores extended ECG data for evaluation of infrequent syncope or arrhythmia (example: Medtronic Reveal).

Typical monitoring durationCan monitor patients for up to approximately 14 months.

Device examples / codesExample device: Medtronic Reveal; CPT code for insertion: 33285; HCPCS codes: C1764, E0616.